A novel multikinase inhibitor SKLB‐YTH‐60 ameliorates inflammation and fibrosis in bleomycin‐induced...
A novel multikinase inhibitor SKLB‐YTH‐60 ameliorates inflammation and fibrosis in bleomycin‐induced lung fibrosis mouse models
About this item
Full title
Author / Creator
Liu, Hongyao , Wu, Xiuli , Gan, Cailing , Wang, Liqun , Wang, Guan , Yue, Lin , Liu, Zhihao , Wei, Wei , Su, Xingping , Zhang, Qianyu , Tan, Zui , Yao, Yuqin , Ouyang, Liang , Yu, Luoting and Ye, Tinghong
Publisher
England: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
England: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Objectives
Idiopathic pulmonary fibrosis (IPF) is marked by the excessive accumulation of extracellular matrix, which participates in a variety of chronic diseases or injuries and seriously threatens human health. Due to the side effects of clinical drugs, there is still a need to develop novel and less toxic drugs to treat pulmonary fibrosis.
Alternative Titles
Full title
A novel multikinase inhibitor SKLB‐YTH‐60 ameliorates inflammation and fibrosis in bleomycin‐induced lung fibrosis mouse models
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8249783
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8249783
Other Identifiers
ISSN
0960-7722
E-ISSN
1365-2184
DOI
10.1111/cpr.13081
